These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20564325)

  • 1. In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer.
    Murphy TM; Sullivan L; Lane C; O'Connor L; Barrett C; Hollywood D; Lynch T; Lawler M; Perry AS
    Prostate; 2011 Jan; 71(1):1-17. PubMed ID: 20564325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.
    Carvalho JR; Filipe L; Costa VL; Ribeiro FR; Martins AT; Teixeira MR; Jerónimo C; Henrique R
    Apoptosis; 2010 Aug; 15(8):956-65. PubMed ID: 20464497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer.
    Murphy TM; Perry AS; Lawler M
    Endocr Relat Cancer; 2008 Mar; 15(1):11-25. PubMed ID: 18310272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
    Perry AS; Loftus B; Moroose R; Lynch TH; Hollywood D; Watson RW; Woodson K; Lawler M
    Br J Cancer; 2007 May; 96(10):1587-94. PubMed ID: 17453001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP7 promoter methylation and gene expression analysis in prostate cancer.
    Sullivan L; Murphy TM; Barrett C; Loftus B; Thornhill J; Lawler M; Hollywood D; Lynch T; Perry AS
    J Urol; 2012 Oct; 188(4):1354-60. PubMed ID: 22906661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer.
    Betz B; Florl AR; Seifert HH; Dall P; Schulz WA; Niederacher D
    Hum Mutat; 2004 Jun; 23(6):612-20. PubMed ID: 15146466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD; Weinstein M; Lin X; Sun Y; Pin SS; Bova GS; Epstein JI; Isaacs WB; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):531-6. PubMed ID: 9641498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
    Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray.
    Bull JH; Ellison G; Patel A; Muir G; Walker M; Underwood M; Khan F; Paskins L
    Br J Cancer; 2001 Jun; 84(11):1512-9. PubMed ID: 11384102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRK inactivation associated with promoter methylation and LOH in prostate cancer.
    Higuchi T; Nakamura M; Shimada K; Ishida E; Hirao K; Konishi N
    Prostate; 2008 Jan; 68(1):105-13. PubMed ID: 18008329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.